rs555853603
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_021098.3(CACNA1H):c.4558G>A(p.Asp1520Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000285 in 1,612,536 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1520G) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.4594G>A | p.Asp1532Asn | missense_variant | Exon 24 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.4519G>A | p.Asp1507Asn | missense_variant | Exon 24 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.4519G>A | p.Asp1507Asn | missense_variant | Exon 24 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.4558G>A | p.Asp1520Asn | missense_variant | Exon 24 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*528G>A | non_coding_transcript_exon_variant | Exon 24 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*2471G>A | non_coding_transcript_exon_variant | Exon 24 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4005G>A | non_coding_transcript_exon_variant | Exon 23 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.4558G>A | non_coding_transcript_exon_variant | Exon 24 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*528G>A | 3_prime_UTR_variant | Exon 24 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000640028.1 | n.*2471G>A | 3_prime_UTR_variant | Exon 24 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*4005G>A | 3_prime_UTR_variant | Exon 23 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152234Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000524 AC: 13AN: 247982 AF XY: 0.0000223 show subpopulations
GnomAD4 exome AF: 0.0000247 AC: 36AN: 1460184Hom.: 0 Cov.: 35 AF XY: 0.0000165 AC XY: 12AN XY: 726372 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74496 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 1520 of the CACNA1H protein (p.Asp1520Asn). This variant is present in population databases (rs555853603, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 460119). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at